191 related articles for article (PubMed ID: 21627336)
1. Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Fogari R; Mugellini A; Circelli M; Cremonesi G
Clin Drug Investig; 2011; 31(7):439-53. PubMed ID: 21627336
[TBL] [Abstract][Full Text] [Related]
2. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
[TBL] [Abstract][Full Text] [Related]
3. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.
Kohlmann O; Roca-Cusachs A; Laurent S; Schmieder RE; Wenzel RR; Fogari R
Adv Ther; 2009 Mar; 26(3):313-24. PubMed ID: 19330493
[TBL] [Abstract][Full Text] [Related]
4. Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.
Coca A
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):147-59. PubMed ID: 17338661
[TBL] [Abstract][Full Text] [Related]
5. Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus.
Mugellini A; Preti P; Zoppi A; Corradi L; Fogari E; Derosa G; Fogari R
J Hum Hypertens; 2004 Oct; 18(10):687-91. PubMed ID: 15071488
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes.
Roca-Cusachs A; Schmieder RE; Triposkiadis F; Wenzel RR; Laurent S; Kohlmann O; Fogari R;
J Hypertens; 2008 Apr; 26(4):813-8. PubMed ID: 18327093
[TBL] [Abstract][Full Text] [Related]
7. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients.
Fogari R; Derosa G; Zoppi A; Lazzari P; Corradi L; Preti P; Mugellini A
Intern Med; 2008; 47(5):361-6. PubMed ID: 18310964
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of irbesartan/ hydrochlorothiazide and valsartan/hydrochlorothiazide combination in lowering blood pressure: a retrospective observational study in Oman.
Al Balushi KA; Habib JQ; Al-Zakwani I
Med Princ Pract; 2013; 22(3):265-9. PubMed ID: 23235349
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the efficacy and safety of irbesartan/hydrochlorothiazide combination therapy with irbesartan monotherapy in the treatment of moderate or severe hypertension in diabetic and obese hypertensive patients: a post-hoc analysis review.
Neutel JM
Postgrad Med; 2011 Jul; 123(4):126-34. PubMed ID: 21680997
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy.
Fogari R; Zoppi A; Mugellini A; Preti P; Destro M; Rinaldi A; Derosa G
Adv Ther; 2006; 23(5):680-95. PubMed ID: 17142202
[TBL] [Abstract][Full Text] [Related]
12. Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.
Smith DH; Dubiel R; Jones M
Am J Cardiovasc Drugs; 2005; 5(1):41-50. PubMed ID: 15631537
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the antihypertensive efficacy of irbesartan/HCTZ and valsartan/HCTZ combination therapy: impact of age and gender.
Asmar R; Oparil S
Clin Exp Hypertens; 2010; 32(8):499-503. PubMed ID: 21091220
[TBL] [Abstract][Full Text] [Related]
14. Olmesartan medoxomil: a review of its use in the management of hypertension.
Scott LJ; McCormack PL
Drugs; 2008; 68(9):1239-72. PubMed ID: 18547134
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
16. [Fast-acting sartan. High blood pressure therapy without long waiting time].
MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
[No Abstract] [Full Text] [Related]
17. Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension.
Bramlage P
Vasc Health Risk Manag; 2009; 5(1):213-24. PubMed ID: 19436667
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.
Maniadakis N; Ekman M; Fragoulakis V; Papagiannopoulou V; Yfantopoulos J
Eur J Health Econ; 2011 Jun; 12(3):253-61. PubMed ID: 20411401
[TBL] [Abstract][Full Text] [Related]
20. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
Ruilope LM; Simpson RL; Toh J; Arcuri KE; Goldberg AI; Sweet CS
Blood Press; 1996 Jan; 5(1):32-40. PubMed ID: 8777471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
